VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_16-vv-00861
Package ID: USCOURTS-cofc-1_16-vv-00861
Petitioner: Michele Meadows
Filed: 2016-07-21
Decided: 2018-08-30
Vaccine: influenza
Vaccination date: 2014-10-03
Condition: Guillain-Barré Syndrome (GBS)
Outcome: compensated
Award amount USD: 300000

AI-assisted case summary:
Michele Meadows filed a petition for compensation on July 21, 2016, alleging that the influenza vaccine she received on October 3, 2014, caused her to develop Guillain-Barré Syndrome (GBS) with residual effects lasting over six months. Respondent, the Secretary of Health and Human Services, denied that the vaccine caused Petitioner's alleged GBS or any other injury. The parties, represented by Maximillian J. Muller of Muller Brazil, LLP for Petitioner and Voris E. Johnson of the United States Department of Justice for Respondent, filed a stipulation for award on July 30, 2018. The stipulation stated that a decision should be entered awarding compensation to Petitioner. Special Master Herbrina Sanders found the stipulation reasonable and adopted it as the decision of the Court. Petitioner was awarded a lump sum of $300,000.00, payable to Michele Meadows, representing compensation for all damages available under 42 U.S.C. § 300aa-15(a). The decision was posted on the website of the United States Court of Federal Claims in accordance with the E-Government Act of 2002. The public decision does not describe the specific onset of symptoms, medical tests, treatments, or expert testimony.

Theory of causation field:
Petitioner Michele Meadows alleged that the influenza vaccine received on October 3, 2014, caused Guillain-Barré Syndrome (GBS) with residual effects lasting over six months. Respondent denied causation. The parties filed a stipulation for award, agreeing to compensation without admitting causation. Special Master Herbrina Sanders adopted the stipulation as the decision of the Court. Petitioner was awarded $300,000.00. The public decision does not detail the specific theory of causation, medical experts, or the mechanism by which the vaccine allegedly caused GBS. The theory of causation is unclear from the provided text.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_16-vv-00861-0
Date issued/filed: 2018-08-30
Pages: 2
Docket text: PUBLIC DECISION (Originally filed: 07/30/2018) regarding 58 DECISION Stipulation/Proffer Signed by Special Master Herbrina Sanders. (rs) Service on parties made.
--------------------------------------------------------------------------------
Case 1:16-vv-00861-UNJ Document 62 Filed 08/30/18 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: July 30, 2018
* * * * * * * * * * * * * * * * * * * * * * * * *
MICHELE MEADOWS, *
*
Petitioner, * No. 16-861V
v. * Special Master Sanders
*
SECRETARY OF HEALTH * Stipulation for Award; Influenza (“flu”)
AND HUMAN SERVICES, * Vaccine; Guillain-Barré Syndrome (“GBS”)
*
Respondent. *
* * * * * * * * * * * * * * * * * * * * * * * * *
Maximillian J. Muller, Muller Brazil, LLP, Dresher, PA, for Petitioner.
Voris E. Johnson, United States Department of Justice, Washington, DC, for Respondent.
DECISION1
On July 21, 2016, Michele Meadows (“Petitioner”) filed a petition for compensation
pursuant to the National Vaccine Injury Compensation Program.2 42 U.S.C. §§ 300aa-10 to -34
(2012). Petitioner alleged that the influenza (“flu”) vaccine she received on October 3, 2014
caused her to develop Guillain-Barré Syndrome (“GBS”). See Stip. at 1, ECF No. 57. Petitioner
further alleged that she experienced the residual effects of her injury for more than six months. Id.
On July 30, 2018, the parties filed a stipulation in which they state that a decision should
be entered awarding compensation to Petitioner. Stip. at 2. Respondent denies that the flu vaccine
caused Petitioner’s alleged GBS, or any other injury. Id. Nevertheless, the parties agree to the
joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable
and adopts it as the decision of the Court in awarding damages, on the terms set forth therein.
1 This decision shall be posted on the website of the United States Court of Federal Claims, in
accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913
(codified as amended at 44 U.S.C. § 3501 note (2012)). As provided by Vaccine Rule 18(b), each
party has 14 days within which to request redaction “of any information furnished by that party:
(1) that is a trade secret or commercial or financial in substance and is privileged or confidential;
or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly
unwarranted invasion of privacy.” Vaccine Rule 18(b).
2 National Childhood Vaccine Injury Act of 1986, Pub L. No. 99-660, 100 Stat. 3755.

Case 1:16-vv-00861-UNJ Document 62 Filed 08/30/18 Page 2 of 2
The parties stipulate that Petitioner shall receive the following compensation:
A lump sum of $300,000.00 in the form of a check payable to
[P]etitioner, Michele Meadows. This amount represents compensation
for all damages that would be available under 42 U.S.C. § 300aa-15(a).
Stip. at 2.
The undersigned approves the requested amount for Petitioner’s compensation.
Accordingly, an award should be made consistent with the stipulation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of
Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3
IT IS SO ORDERED.
s/Herbrina D. Sanders
Herbrina D. Sanders
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of
notice renouncing the right to seek review.
2